Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19

The severity of the COVID-19 pandemic and the pace of its global spread have motivated researchers to opt for repurposing existing drugs against SARS-CoV-2 rather than discover or develop novel ones. For reasons of speed, throughput, and cost-effectiveness, virtual screening campaigns, relying heavi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bing, Svetlov, Dmitri, Bartikofsky, Dylan, Wobus, Christiane E., Artsimovitch, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228142/
https://www.ncbi.nlm.nih.gov/pubmed/35744940
http://dx.doi.org/10.3390/molecules27123815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228142/
https://www.ncbi.nlm.nih.gov/pubmed/35744940
http://dx.doi.org/10.3390/molecules27123815

Ejemplares similares